Studies have shown that active fund managers routinely underperform the S&P500 index*​

Jade Biosciences, Inc. (NASDAQ: JBIO)

JBIO Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
183.90%

JBIO Stock Analysis

JBIO PE Ratio:

JBIO PEG Ratio: Not Available

JBIO Forward EPS Growth (12 month): 0.00%

JBIO PS Ratio:

JBIO PSG Ratio: Not Available

JBIO Forward Revenue Growth (12 month): 0.00%

JBIO Articles

No data was found